[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1989

Cutaneous LeishmaniasisTreatment With Itraconazole

Author Affiliations

From the Department of Dermatology, S. Gerardo Hospital, Monza, Italy.

Arch Dermatol. 1989;125(11):1540-1542. doi:10.1001/archderm.1989.01670230082014
Abstract

• The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.

(Arch Dermatol. 1989;125:1540-1542)

×